Non-Melanoma Skin Cancer Market Witnesses Strong Pipeline Activity...

adicionou um novo artigo Health

2025-11-06 09:57:55 -

Non-Melanoma Skin Cancer Market Witnesses Strong Pipeline Activity in Pharmaceutical Sector

The global non-melanoma skin cancer (NMSC) market is set for robust expansion over the next decade, driven by rising disease prevalence, technological advancements in diagnostics and therapeutics, and growing awareness about early treatment. The market, valued at US$ 678.6 million in 2025, is projected to reach US$ 1,036.5 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.2%...

0 Comentários 0 Compartilhamentos 15 Visualizações 0 Anterior